Oxford Nanopore Technologies Ltd (LSE:ONT) — Market Cap & Net Worth
Market Cap & Net Worth: Oxford Nanopore Technologies Ltd (ONT)
Oxford Nanopore Technologies Ltd (LSE:ONT) has a market capitalization of $13.79 Million (GBX113.30 Billion) as of June 20, 2026. Listed on the LSE stock exchange, this UK-based company holds position #26229 globally and #306 in its home market, demonstrating a -2.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxford Nanopore Technologies Ltd's stock price GBX116.50 by its total outstanding shares 972516815 (972.52 Million). Review Oxford Nanopore Technologies Ltd (ONT) financial obligations to assess the company's total debt and financial obligations.
Oxford Nanopore Technologies Ltd Market Cap History: 2021 to 2026
Oxford Nanopore Technologies Ltd's market capitalization history from 2021 to 2026. Data shows change from $82.59 Million to $13.79 Million (-29.64% CAGR).
Oxford Nanopore Technologies Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxford Nanopore Technologies Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Oxford Nanopore Technologies Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $82.59 Million | $133.66 Million | -$167.61 Million | 0.62x | N/A |
| 2022 | $29.17 Million | $198.60 Million | -$91.03 Million | 0.15x | N/A |
| 2023 | $24.64 Million | $169.67 Million | -$154.51 Million | 0.15x | N/A |
| 2024 | $15.24 Million | $183.19 Million | -$146.19 Million | 0.08x | N/A |
| 2025 | $15.19 Million | $223.90 Million | -$145.20 Million | 0.07x | N/A |
Competitor Companies of ONT by Market Capitalization
Companies near Oxford Nanopore Technologies Ltd in the global market cap rankings as of June 20, 2026.
Key companies related to Oxford Nanopore Technologies Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Oxford Nanopore Technologies Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Oxford Nanopore Technologies Ltd's market cap moved from $82.59 Million to $ 13.79 Million, with a yearly change of -29.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX13.79 Million | -9.27% |
| 2025 | GBX15.19 Million | -0.31% |
| 2024 | GBX15.24 Million | -38.14% |
| 2023 | GBX24.64 Million | -15.54% |
| 2022 | GBX29.17 Million | -64.68% |
| 2021 | GBX82.59 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Oxford Nanopore Technologies Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.79 Million USD |
| MoneyControl | $13.79 Million USD |
| MarketWatch | $13.79 Million USD |
| marketcap.company | $13.79 Million USD |
| Reuters | $13.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more